Ultra-fine grain traditional Chinese medicine defibrination paste used for treating liver cirrhosis

Abstract

The invention relates to an ultra-fine grain traditional Chinese medicine defibrination paste used for treating liver cirrhosis, comprising the following drug ingredients: tortoise platron, carapax trionycis, radix astragali, large head atractylodes rhizome, Chinese lobelia herb, salvia miltiorrhiza bunge, spreading hedyotis herb, chicken gizzard membrane, radix bupleuri, towel gourd vegetable sponge, beautiful sweetgum fruit, liquoric root, white paeony root, Szechuan lovage rhizome, ridge and zedoary root; all the drugs are processed into ultra-fine drug powder; sesame oil and yellow lead are mixed with the ultra-fine drug powder and the mixture is made into the ultra-fine grain traditional Chinese medicine defibrination paste; when in use, the paste is taken and is externally stuck at the area of the liver. The ultra-fine grain traditional Chinese medicine defibrination paste used for treating liver cirrhosis can improve cellular immune function, adjust humoral immunity, restrain fibroplasia of the liver and promote fiber adsorption of the liver, thus achieving the effect of reversing liver fibrosis. The defibrination paste has the advantages of having rich materials, easy preparation, low cost, treatment of internal disease with external therapy, simple treatment, convenient use, effective drugs, fast effect and good therapeutic effect and simultaneously overcoming adverse reaction of alimentary canal caused by orally taking traditional Chinese medicine by patients with dysfunction of intestines and stomach.

Description

technical field [0001] The invention belongs to traditional Chinese medicine for external application of liver cirrhosis, in particular to an ultrafine traditional Chinese medicine Jiangxian ointment for treating liver fibrosis in early liver cirrhosis. Background technique [0002] Liver cirrhosis is a common clinical disease, frequently-occurring disease, and difficult disease. Most chronic liver diseases have liver fibrosis. Liver fibrosis is the most important pathological feature of chronic liver diseases. Liver fibrosis and liver cirrhosis are both related and different. From a pathological point of view, only diffuse hepatic fibrosis increase is called liver fibrosis, while diffuse liver fibrosis accompanied by destruction of liver lobular structure is called liver cirrhosis; from a pathogenic point of view, liver fibrosis is the The early lesions of the liver are reversible, while cirrhosis is the result of further development of liver fibrosis, causing liver failure...

AI Technical Summary

Problems solved by technology

At present, Western medicine mainly uses anti-viral, anti-immune, interferon and other drugs to treat liver fibrosis, but the cost is expensive, the side effects are many, and the curative effect is not exact. There are different degrees of adverse reactions in oral preparations. Nausea, vomiting and other gastric discomforts occur after taking the medicine. At the same time, due to the traditional production and processing methods used in the production process, the quality of the medicine is difficult to control, so the efficacy of the medicine is limited.